Cogent Biosciences, Inc. (COGT)

NASDAQ

$31.56

$+0.41

(+1.31%)

Regular Market

Cogent Biosciences, Inc. (COGT) Live Price Chart

Last updated: ⁦2026-10-21 18:56:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Cogent Biosciences, Inc. (COGT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $31.56, with a market capitalization of $5.21B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $13.78 to $43.73. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$5.21B
Open	$31.26
Day's High	$153.00
Day's Low	$3.67
Previous Close	$31.24
Volume	1.01M
Average Volume	1.99M
P/E Ratio	--
52-Week High	$43.73
52-Week Low	$13.78
Dividend Yield	--
Earnings Date	--

Cogent Biosciences, Inc. (COGT) Stock Price Today

Cogent Biosciences, Inc. (COGT) is currently trading at $31.56 as of 2026-10-21 18:40:50, up 1.01% ($0.32) from the previous close of $31.24

During today's regular trading session, COGT has traded between $3.67 and $153.00, with a trading volume of 1.01M shares. The current price is near the lower end of today's range.

Cogent Biosciences, Inc. (COGT) 7-Day Stock Price Change

Over the past seven days, Cogent Biosciences, Inc. (COGT) moved from $29.78 to $31.56, representing a gain of 5.96% ($1.78).

The stock traded between $27.74 and $31.90 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 2.55 million shares, up versus the previous seven-day period, indicating higher trading activity.

COGT 52-Week Price Position

Position in Range: 59.4%

52W Low$13.78

52W High$43.73

COGT is currently trading at $31.56, placing it 59.4% of the way from its 52-week low of $13.78 to its 52-week high of $43.73. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Cogent Biosciences, Inc. (COGT)?

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Cogent Biosciences, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	258
Exchange	NASDAQ
Company Website	https://www.cogentbio.com

How to Buy Cogent Biosciences, Inc. (COGT) Stock on MEXC

Eligible investors can buy real shares of Cogent Biosciences, Inc. (COGT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for COGT and Place Your Order

Open the RealStocks trading page and search for COGT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Cogent Biosciences, Inc. (COGT) stock price today?

Cogent Biosciences, Inc. (COGT) is currently trading at $ 31.56, up 1.01% ($0.32) from the previous close of $ 31.24. Intraday prices update in real time during regular trading hours.

2.Is COGT stock going up or down today?

As of 2026-10-21 18:40:50, COGT is trading at $ 31.56, up 1.01% ($0.32) from its previous close of $ 31.24. The stock has traded between $ 3.67 and $ 153.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is COGT pre-market price?

As of 2026-10-21 18:40:50, COGT is trading at $ 30.60 in pre-market trading, down 2.05% ($0.64) from the previous close of $ 31.24. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is COGT after-hours price?

As of 2026-10-21 18:40:50, COGT is trading at $ 31.24 in after-hours trading, unchanged from the regular-session close of $ 31.24. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is COGT stock trading now?

COGT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does COGT sit relative to its 52-week high and low?

Over the past 52 weeks, COGT has traded between a low of $ 13.78 and a high of $ 43.73. At $ 31.56, the stock is positioned 59.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Cogent Biosciences, Inc. in?

Cogent Biosciences, Inc. (COGT) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Cogent Biosciences, Inc.'s market capitalization and where is it listed?

Cogent Biosciences, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 5.21B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is COGT valued in terms of P/E ratio and EPS?

COGT trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.92. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Cogent Biosciences, Inc. pay a dividend?

Cogent Biosciences, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.